Teva Pharmaceutical Industries Limited And IVAX Corporation Receive European Commission Approval For Acquisition
JERUSALEM & MIAMI--(BUSINESS WIRE)--Nov. 25, 2005--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and IVAX Corporation (AMEX: IVX) announced today that they received unconditional approval from the European Commission to proceed with Teva's acquisition of IVAX.